Integrating Pharmacology and Microbial Network Analysis with Experimental Validation to Reveal the Mechanism of Composite Sophora Colon-Soluble Capsule Against Ulcerative Colitis

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2020 May 9

PMID 32382313

Citations 9

Authors

Yuxuan Ding

Mingjun Chen

Qiying Wang

Lu Gao

Yang Feng

Shida Wang

Zitian Song

ZhanQi Tong

Affiliations

Soon will be listed here.

Abstract

Ulcerative colitis (UC) has multifactorial pathogenesis that acts synergistically, such as immune system dysregulation and expansion of infectious gut microbiota. Therefore, a multicomponent treatment derived from Chinese herbal medicine that interacts with multiple targets synergistically is needed. Composite sophora colon-soluble capsule (CSCC) is a Chinese herbal formula that has shown therapeutic efficacy against UC in randomized clinical trials. However, its bioactive components and potential target genes against UC remain unclear. Here, we used a network pharmacology approach to detect component-target-pathway interactions of CSCC against UC. A total of 29 gene targets, 91 bioactive components, and 20 enriched pathways of CSCC were identified. The IL-17 signaling pathway activated by infectious gastrointestinal microbes and predicted by the network analysis to be a major pathway modulated by CSCC against UC was studied in a dextran sulfate sodium-induced colitis model. CSCC showed remarkable efficacy against UC with respect to the attenuation of colon length, body weight loss, and disease activity index through gut microbiota recovery and intestinal immune homeostasis. The rectal administration of CSCC reduced the numbers of Th17 cells isolated from both mesenteric lymph nodes and lamina propria mononuclear cells and the levels of IL-17A, IL-6, IL-1, and TNF-. Additionally, the percentage of Treg cells and the levels of their hallmark cytokines were upregulated. Rectal administration of CSCC led to microbiota regulation with a significant correlation between suppression of Verrucomicrobiaceae and Ruminococcaceae, as well as the elevation of Lactobacillaceae, and CSCC administration via microbiome correlation heatmaps and cooccurrence network analysis at multiple time points. Thus, our study presents an effective herbal formula, CSCC, for UC treatment and explores its components and mechanisms of efficacy through the examination of gut microbiota and hallmark cytokines in the IL-17 pathway.

Citing Articles

Co-frequency or contrary? The effects of Qiwei Baizhu Powder and its bioactive compounds on mucosa-associated microbiota of mice with antibiotic-associated diarrhea.

Zhang Z, Yang Y, Zhang Y, Xie G Front Cell Infect Microbiol. 2024; 14:1483048.

PMID: 39529635 PMC: 11551125. DOI: 10.3389/fcimb.2024.1483048.

Wuwei Kushen Changrong capsule alleviates DSS-induced colitis in mice via inhibition of NLRP3 inflammasome and STAT3 pathway.

Chen M, Feng Y, Luo D, Zhang C, Zhou J, Dai H Front Pharmacol. 2024; 15:1423012.

PMID: 39329121 PMC: 11424895. DOI: 10.3389/fphar.2024.1423012.

Exploring shared mechanisms between ulcerative colitis and psoriasis and predicting therapeutic natural compounds through bioinformatics and molecular docking.

Yang Y, Gong Z, Yang J, Cai Y, Hong S, Mao W Heliyon. 2024; 10(18):e37624.

PMID: 39309918 PMC: 11416260. DOI: 10.1016/j.heliyon.2024.e37624.

Chinese herbal medicines for treating ulcerative colitis via regulating gut microbiota-intestinal immunity axis.

Yang Y, Wang Y, Zhao L, Wang F, Li M, Wang Q Chin Herb Med. 2023; 15(2):181-200.

PMID: 37265772 PMC: 10230642. DOI: 10.1016/j.chmed.2023.03.003.

Evaluation of the Mechanism of Sinomenii Caulis in Treating Ulcerative Colitis based on Network Pharmacology and Molecular Docking.

Tian J, Yang C, Wang Y, Zhou C Curr Comput Aided Drug Des. 2023; 20(3):195-207.

PMID: 37078344 PMC: 10641851. DOI: 10.2174/1573409919666230420083102.

References

Martinez-Lopez M, Iborra S, Conde-Garrosa R, Mastrangelo A, Danne C, Mann E . Microbiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and -22 Production and Promotes Intestinal Barrier Integrity. Immunity. 2019; 50(2):446-461.e9. PMC: 6382412. DOI: 10.1016/j.immuni.2018.12.020. View

Yan Y, Shao M, Qi Q, Xu Y, Yang X, Zhu F . Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages. Acta Pharmacol Sin. 2018; 39(10):1633-1644. PMC: 6289314. DOI: 10.1038/aps.2017.185. View

Wang C, Li W, Wang H, Ma Y, Zhao X, Yang H . VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice. World J Gastroenterol. 2018; 24(37):4254-4262. PMC: 6175759. DOI: 10.3748/wjg.v24.i37.4254. View

Chudnovskiy A, Mortha A, Kana V, Kennard A, Ramirez J, Rahman A . Host-Protozoan Interactions Protect from Mucosal Infections through Activation of the Inflammasome. Cell. 2016; 167(2):444-456.e14. PMC: 5129837. DOI: 10.1016/j.cell.2016.08.076. View

Lee W, Lee C, Kim Y, Kim C . The Methodological Trends of Traditional Herbal Medicine Employing Network Pharmacology. Biomolecules. 2019; 9(8). PMC: 6723118. DOI: 10.3390/biom9080362. View

Naganuma M, Mizuno S, Nanki K, Sugimoto S, Kanai T . Recent trends and future directions for the medical treatment of ulcerative colitis. Clin J Gastroenterol. 2016; 9(6):329-336. DOI: 10.1007/s12328-016-0686-z. View

Feng S, Dai Z, Liu A, Wang H, Chen J, Luo Z . β-Sitosterol and stigmasterol ameliorate dextran sulfate sodium-induced colitis in mice fed a high fat Western-style diet. Food Funct. 2017; 8(11):4179-4186. PMC: 5875920. DOI: 10.1039/c7fo00375g. View

Reimand J, Isserlin R, Voisin V, Kucera M, Tannus-Lopes C, Rostamianfar A . Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap. Nat Protoc. 2019; 14(2):482-517. PMC: 6607905. DOI: 10.1038/s41596-018-0103-9. View

McIlroy J, Ianiro G, Mukhopadhya I, Hansen R, Hold G . Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management. Aliment Pharmacol Ther. 2017; 47(1):26-42. DOI: 10.1111/apt.14384. View

10.

Hoffmann M, Schwertassek U, Seydel A, Weber K, Falk W, Hauschildt S . A refined and translationally relevant model of chronic DSS colitis in BALB/c mice. Lab Anim. 2017; 52(3):240-252. DOI: 10.1177/0023677217742681. View

11.

Yu W, Su X, Chen W, Tian X, Zhang K, Guo G . Three types of gut bacteria collaborating to improve Kui Jie'an enema treat DSS-induced colitis in mice. Biomed Pharmacother. 2019; 113:108751. DOI: 10.1016/j.biopha.2019.108751. View

12.

Lin Y, Luck H, Khan S, Schneeberger P, Tsai S, Clemente-Casares X . Aryl hydrocarbon receptor agonist indigo protects against obesity-related insulin resistance through modulation of intestinal and metabolic tissue immunity. Int J Obes (Lond). 2019; 43(12):2407-2421. PMC: 6892742. DOI: 10.1038/s41366-019-0340-1. View

13.

Wang P, Dai L, Zhou W, Meng J, Zhang M, Wu Y . Intermodule Coupling Analysis of Huang-Lian-Jie-Du Decoction on Stroke. Front Pharmacol. 2019; 10:1288. PMC: 6848980. DOI: 10.3389/fphar.2019.01288. View

14.

Barbosa Bezerra G, de Menezes de Souza L, Dos Santos A, de Almeida G, Souza M, Lauton Santos S . Hydroalcoholic extract of Brazilian red propolis exerts protective effects on acetic acid-induced ulcerative colitis in a rodent model. Biomed Pharmacother. 2016; 85:687-696. DOI: 10.1016/j.biopha.2016.11.080. View

15.

Li J, Doty A, Tang Y, Berrie D, Iqbal A, Tan S . Enrichment of IL-17A IFN-γ and IL-22 IFN-γ T cell subsets is associated with reduction of NKp44 ILC3s in the terminal ileum of Crohn's disease patients. Clin Exp Immunol. 2017; 190(1):143-153. PMC: 5588779. DOI: 10.1111/cei.12996. View

16.

Cooper H, Murthy S, Shah R, Sedergran D . Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993; 69(2):238-49. View

17.

Abdel-Gadir A, Stephen-Victor E, Gerber G, Noval Rivas M, Wang S, Harb H . Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy. Nat Med. 2019; 25(7):1164-1174. PMC: 6677395. DOI: 10.1038/s41591-019-0461-z. View

18.

Rottjers L, Faust K . From hairballs to hypotheses-biological insights from microbial networks. FEMS Microbiol Rev. 2018; 42(6):761-780. PMC: 6199531. DOI: 10.1093/femsre/fuy030. View

19.

Rangan P, Choi I, Wei M, Navarrete G, Guen E, Brandhorst S . Fasting-Mimicking Diet Modulates Microbiota and Promotes Intestinal Regeneration to Reduce Inflammatory Bowel Disease Pathology. Cell Rep. 2019; 26(10):2704-2719.e6. PMC: 6528490. DOI: 10.1016/j.celrep.2019.02.019. View

20.

Mitchell J, Kim S, Koukos G, Seelmann A, Veit B, Shepard B . Colonic Inhibition of Phosphatase and Tensin Homolog Increases Colitogenic Bacteria, Causing Development of Colitis in Il10-/- Mice. Inflamm Bowel Dis. 2018; 24(8):1718-1732. PMC: 6231371. DOI: 10.1093/ibd/izy124. View